MediPharm Labs (LABS) Competitors C$0.07 0.00 (0.00%) As of 03:53 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock LABS vs. HLS, TGOD, NINE, SUGR, WMD, MDP, HEXO, VIR, ZOM, and WLLWShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include HLS Therapeutics (HLS), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), SugarBud Craft Growers (SUGR), WeedMD (WMD), Medexus Pharmaceuticals (MDP), HEXO (HEXO), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), and Willow Biosciences (WLLW). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. Its Competitors HLS Therapeutics Green Organic Dutchman Delta 9 Cannabis SugarBud Craft Growers WeedMD Medexus Pharmaceuticals HEXO Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) Willow Biosciences MediPharm Labs (TSE:LABS) and HLS Therapeutics (TSE:HLS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation. Do insiders and institutionals believe in LABS or HLS? 0.7% of MediPharm Labs shares are held by institutional investors. Comparatively, 65.2% of HLS Therapeutics shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Comparatively, 0.4% of HLS Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts prefer LABS or HLS? HLS Therapeutics has a consensus target price of C$4.50, indicating a potential downside of 8.16%. Given HLS Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe HLS Therapeutics is more favorable than MediPharm Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MediPharm Labs 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00HLS Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable earnings and valuation, LABS or HLS? MediPharm Labs has higher earnings, but lower revenue than HLS Therapeutics. HLS Therapeutics is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediPharm LabsC$39.42M0.74-C$12.05M-C$0.03-2.41HLS TherapeuticsC$40.13M2.72-C$15.53M-C$1.00-4.91 Is LABS or HLS more profitable? MediPharm Labs has a net margin of -30.56% compared to HLS Therapeutics' net margin of -38.70%. MediPharm Labs' return on equity of -24.41% beat HLS Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets MediPharm Labs-30.56% -24.41% -7.17% HLS Therapeutics -38.70%-25.27%-2.89% Which has more volatility & risk, LABS or HLS? MediPharm Labs has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, HLS Therapeutics has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Does the media refer more to LABS or HLS? In the previous week, MediPharm Labs' average media sentiment score of 0.00 equaled HLS Therapeutics'average media sentiment score. Company Overall Sentiment MediPharm Labs Neutral HLS Therapeutics Neutral SummaryHLS Therapeutics beats MediPharm Labs on 7 of the 13 factors compared between the two stocks. Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$29.05MC$2.17BC$5.52BC$6.26BDividend YieldN/A2.92%3.80%6.72%P/E Ratio-2.414.2428.0454.38Price / Sales0.74582.79429.531,113.49Price / Cash1.3010.3535.8483.29Price / Book0.6411.338.124.96Net Income-C$12.05MC$21.15BC$3.25BC$301.20M7 Day PerformanceN/A1.25%0.97%0.51%1 Month PerformanceN/A6.17%7.36%4.13%1 Year PerformanceN/A3.88%31.31%25.62% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.07flatN/A-6.7%C$29.05MC$39.42M-2.41130Gap DownHLSHLS TherapeuticsN/AC$4.90+0.2%C$4.50-8.2%+42.3%C$109.01MC$40.13M-4.9191TGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940News CoverageGap UpSUGRSugarBud Craft GrowersN/AC$13.00flatN/A+57.3%C$88.66MC$575.64M15.6644WMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpMDPMedexus Pharmaceuticals1.5692 of 5 starsC$2.80-4.8%C$5.49+96.0%+26.3%C$62.69MC$100.25M13.3998HEXOHEXON/AN/AN/AN/AC$38.72MC$124.10M-0.26690VIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap DownWLLWWillow BiosciencesN/AC$0.25+6.4%N/A+138.1%C$36.21MC$2.94M-4.5719Gap Up Related Companies and Tools Related Companies HLS Therapeutics Competitors Green Organic Dutchman Competitors Delta 9 Cannabis Competitors SugarBud Craft Growers Competitors WeedMD Competitors Medexus Pharmaceuticals Competitors HEXO Competitors Viridium Pacific Group Competitors Zomedica Pharmaceuticals Corp. (ZOM.V) Competitors Willow Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:LABS) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
